We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.55B
AUM Growth
-$472M
Cap. Flow
-$301M
Cap. Flow %
-3.99%
Top 10 Hldgs %
20.77%
Holding
863
New
59
Increased
344
Reduced
256
Closed
128

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$25.4M
2
ABBV icon
AbbVie
ABBV
+$21.9M
3
KYNB
Kyntra Bio
KYNB
+$19.2M
4
WM icon
Waste Management
WM
+$19M
5
GILD icon
Gilead Sciences
GILD
+$17.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$70.2M
2
ARRY
Array Biopharma Inc
ARRY
+$45.8M
3
BIIB icon
Biogen
BIIB
+$43.3M
4
META icon
Meta Platforms (Facebook)
META
+$24.8M
5
AMGN icon
Amgen
AMGN
+$21.7M

Sector Composition

Rank Sector Weight
1 Healthcare 31.81%
2 Technology 18.27%
3 Financials 10.05%
4 Consumer Discretionary 9.39%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APHA
801
DELISTED
Aphria Inc. Common Shares
APHA
– –
-11,000
Closed -$77K
HDS
802
DELISTED
HD Supply Holdings, Inc.
HDS
– –
-25,657
Closed -$1.03M
TTPH
803
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-781
Closed -$7K
FTSV
804
DELISTED
Forty Seven, Inc. Common Stock
FTSV
– –
-109,612
Closed -$1.16M
ONCE
805
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-62,007
Closed -$6.32M
STI
806
DELISTED
SunTrust Banks, Inc.
STI
– –
-64,780
Closed -$4.05M
VIAB
807
DELISTED
Viacom Inc. Class B
VIAB
– –
-204,753
Closed -$6.09M
GHDX
808
DELISTED
Genomic Health, Inc.
GHDX
– –
-30,765
Closed -$1.78M
LTXB
809
DELISTED
LegacyTexas Financial Group Inc
LTXB
– –
-157,388
Closed -$6.38M
NRCG
810
DELISTED
NRC Group Holdings Corp.
NRCG
– –
-174,159
Closed -$1.93M
MDSO
811
DELISTED
Medidata Solutions, Inc.
MDSO
– –
-3,000
Closed -$270K
ALDR
812
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-227,500
Closed -$2.67M
ISCA
813
DELISTED
International Speedway Corp
ISCA
– –
-75,631
Closed -$3.38M
VSM
814
DELISTED
Versum Materials, Inc.
VSM
– –
-222,816
Closed -$11.4M
BID
815
DELISTED
Sotheby's
BID
– –
-25,356
Closed -$1.47M
OAK
816
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
– –
-177,998
Closed -$8.78M
SFLY
817
DELISTED
Shutterfly, Inc.
SFLY
– –
-7,534
Closed -$379K
CRAY
818
DELISTED
Cray, Inc.
CRAY
– –
-88,567
Closed -$3.07M
AQ
819
DELISTED
Aquantia Corp. Common Stock
AQ
– –
-355,454
Closed -$4.61M
APC
820
DELISTED
Anadarko Petroleum
APC
– –
-154,072
Closed -$10.8M
DATA
821
DELISTED
Tableau Software, Inc.
DATA
– –
-71,902
Closed -$11.9M
WP
822
DELISTED
Worldpay, Inc.
WP
– –
-116,355
Closed -$14.2M
ARRY
823
DELISTED
Array Biopharma Inc
ARRY
– –
-992,510
Closed -$45.8M
LEXEA
824
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
– –
-127,236
Closed -$6.05M
BRSS
825
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
– –
-65,949
Closed -$2.87M
30 31 32
33
34

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2019 Portfolio in Review

As of Q3 2019, Candriam SCA held 863 positions worth $7.55B, down 5.9% from $8.02B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA withdrew a net $301M in Q3 2019, closing 128 positions and reducing 256 holdings. Its most notable exit was Celgene Corp, an estimated $70.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Nike worth $27.8M.

  • Candriam SCA's largest Q3 2019 buy was Nike: 295,763 shares worth $27.8M.
  • Candriam SCA added most to AbbVie in Q3 2019, an estimated $21.9M increase.
  • Candriam SCA's biggest Q3 2019 reduction was Biogen, cutting an estimated $43.3M.
  • Candriam SCA fully exited Celgene Corp in Q3 2019, selling an estimated $70.2M.
  • Candriam SCA's ten largest holdings make up 21% of its $7.55B portfolio in Q3 2019.
  • Candriam SCA opened 59 new positions and closed 128 in Q3 2019.
  • Candriam SCA's portfolio value fell 5.9% quarter-over-quarter to $7.55B.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.